Women are less likely than men to engage in sexually agentic behavior (e.g., initiating sexual encounters), despite the benefits associated with sexual agency (Kiefer & Sanchez, 2007). Two studies examined possible explanations, related to person perception, for gender differences in sexually agentic behavior. In Study 1, participants viewed the dating profiles of targets who were either high or low on sexual agency and rated sexually agentic targets as more desirable but also riskier sexual partners (i.e., having more previous sexual partners), as well as more selfish partners overall. Participants believed the agentic female targets to be the most desirable but also to have the highest number of previous sexual partners. In Study 2, female participants weighed the importance and consequences of sexual agency differently than male participants. Based on the two studies, we suggest that although men and women are judged similarly for sexual agency, women may refrain from sexual agency because they view the traits and characteristics that are perceived to go hand in hand with sexual agency more negatively.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10508-014-0408-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Surveillance for variants escaping detection with the Aptima Combo 2 assay in Canada from 2019 to 2021.
Microbiol Spectr
January 2025
National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Unlabelled: Nucleic acid amplification tests (NAATs) are the method of choice for diagnosis, but these strategies are susceptible to target site mutations. variants escaping detection with the Aptima Combo 2 (AC2) assay on the Hologic Panther instrument from 23S rRNA mutations have been reported in Nordic countries, England, Japan, and the United States. Given the potential for false negative results, this study investigated whether strains of with AC2 target site mutations were present in Canada.
View Article and Find Full Text PDF"If that would have lessened my symptoms, that would have been great...": a qualitative study about the acceptability of tecovirimat as treatment for mpox.
BMC Med
January 2025
Health Emergencies Programme, World Health Organization, Geneva, Switzerland.
Background: Tecovirimat, an antiviral treatment for smallpox, was approved as a treatment for mpox by the European Medicines Agency in January 2022. Approval was granted under "exceptional circumstances" based on effectiveness found in pre-clinical challenge studies in animals and safety studies in humans showing minimal side effects. As clinical efficacy studies are still ongoing, there is currently limited information with regard to the acceptability of tecovirimat to treat mpox.
View Article and Find Full Text PDFEmergency Healthcare Utilization and Unmet Care Needs in Chemsex Users: A Cross-Sectional Survey among Sexual Minority Men.
J Community Health
January 2025
National Health School, Carlos III Health Institute, Madrid, Spain.
Chemsex entails potential risks that may lead to medical emergencies. This cross-sectional study analyzed data from an anonymous, self-administered online survey on substance use among 1,203 sexual minority men (SMM) who engage in chemsex in Spain. The study aimed to determine the proportion of chemsex users that have sought emergency care following a session, identify their reasons for consultation, examine associated sociodemographic factors, and assess the proportion who felt they should have sought emergency care but did not.
View Article and Find Full Text PDF: trans and gender diverse people's perspectives on sexual health services in the United Kingdom.
Sex Transm Infect
January 2025
Objectives: Trans and/or gender diverse (T/GD) people in the UK are less likely to access sexual health services (SHS) than cisgender people and are more likely to report negative experiences. The British Association for Sexual Health and HIV (BASHH) developed expert recommendations for T/GD-inclusive SHS, but these lack service user perspectives. This study addressed this gap by asking T/GD people how SHS could be T/GD-inclusive.
View Article and Find Full Text PDFA phylogenetic assessment of in (, ): introduction of new genera, and the resurrection of .
Fungal Syst Evol
December 2024
Plant Microbe Interaction Research Team, BIOTEC, National Science and Technology Development Agency (NSTDA) 111 Thailand Science Park, Phahonyothin Road, Khlong Nueng, Khlong Luang, Pathum Thani, 12120, Thailand.
During entomopathogenic fungal surveys conducted in Thailand, 15 specimens tentatively classified under were identified. To gain a comprehensive understanding of their taxonomy, molecular phylogenies using combined LSU, , , and sequence data, together with morphological examination of several spp. from previous studies were conducted.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!